Please see below for a selection of interesting articles on pediatric CML in peer-reviewed journals. Latest publications include:

• Long-term safety and efficacy of imatinib in pediatric patients with chronic myeloid leukemia: Single-Center experience from China
  Cai Y et al. Int J Hematol, January 2021 (epub ahead of print)
• Successful haploidentical stem cell transplant with posttransplant cyclophosphamide for isolated central nervous system blast crisis in a child with CML
  Chatterjee G et al. J Pediatr Hematol Oncol, January 2021
• Sudden blast phase in pediatric chronic meloid leukemia-chronic phase with abnormal blasts detected by flow cytometry at diagnosis: Can it be considered a worsening sign?
  Vijayasekharan K et al. Cytometry C Clin Cytom, October 2020 (epub ahead of print)
• Factors and outcomes of chronic myeloid leukemia at very young age: Data from the International Pediatric Chronic Myeloid Leukemia Registry
  Meral Günes A et al. Pediatr Blood Cancer, October 2020 (epub ahead of publication)
• Foveal photoreceptors loss and then recovery after treatment in a chronic myelogenous leukemia patient
  Hsia NY et al. Pediatr Hematol Oncol, September 2020
• Lymphoblastic predominance of blastic phase in children with chronic myeloid leukemia treated with imatinib: A report from the I-CML-Ped Study
  Meyran D et al. Eur J Cancer, August 2020 (epub ahead of print)
  
• Sustained molecular response following a failed attempt of tyrosine kinase inhibitor discontinuation and the effects on growth in a child with CML: not always a short story
  Triche L et al. Pediatr Hematol Oncol, August 2020
• A case of childhood blastic phase chronic myeloid leukemia with minor BCR-ABL
  Yamanaka J et al. J Pediatr Hematol Oncol, August 2021

Search here for more publications on pediatric CML